Browse Studies — Arctuva

Phase 2

The Alzheimer's Disease Tau Platform Clinical Trial

The goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with the anti-amy…

Preclinical Alzheimer's DiseaseAlzheimer DiseaseProdromal Alzheimer's Disease

Estimated

~$10 – $7,500

Paul S. AisenNCT06957418

Phase 1

A Phase 1b/2, Multicenter, Adaptive, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Immunogenicity, and Pharmacodynamic Effects of ACI-24.060 in Subjects With Prodromal Alzheimer's Disease and in Adults With Down Syndrome (ABATE)

The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer'…

Amyloid PlaqueBeta-AmyloidDSAD+2 more

Estimated

~$10 – $7,500

AC Immune SANCT05462106

Observational

Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease

Interventions that affect many different aspects of human ability rather than just one aspect of human health are more likely to be successful in preventing an…

Prodromal Alzheimer's Disease

Estimated

~$10 – $6,250

Emory UniversityNCT04029623